Advisor Group’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $94K | Sell |
161
-112
| -41% | -$65.4K | ﹤0.01% | 2987 |
|
|
2019
Q3 | $180K | Buy |
273
+25
| +10% | +$16.5K | ﹤0.01% | 2399 |
|
|
2019
Q2 | $192K | Sell |
248
-185
| -43% | -$143K | ﹤0.01% | 2343 |
|
|
2019
Q1 | $306K | Sell |
433
-20
| -4% | -$14.1K | ﹤0.01% | 1958 |
|
|
2018
Q4 | $211K | Sell |
453
-32
| -7% | -$14.9K | ﹤0.01% | 2053 |
|
|
2018
Q3 | $417K | Buy |
485
+82
| +20% | +$70.5K | ﹤0.01% | 1601 |
|
|
2018
Q2 | $278K | Buy |
403
+43
| +12% | +$29.7K | ﹤0.01% | 1727 |
|
|
2018
Q1 | $161K | Buy |
360
+171
| +90% | +$76.5K | ﹤0.01% | 2149 |
|
|
2017
Q4 | $82K | Sell |
189
-31
| -14% | -$13.5K | ﹤0.01% | 2731 |
|
|
2017
Q3 | $109K | Buy |
220
+44
| +25% | +$21.8K | ﹤0.01% | 2328 |
|
|
2017
Q2 | $97K | Buy |
176
+17
| +11% | +$9.37K | ﹤0.01% | 2330 |
|
|
2017
Q1 | $105K | Buy |
159
+88
| +124% | +$58.1K | ﹤0.01% | 2128 |
|
|
2016
Q4 | $24K | Buy |
71
+70
| +7,000% | +$23.7K | ﹤0.01% | 3113 |
|
|
2016
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 4615 |
|
|
2016
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4509 |
|